South San Francisco-based Novome Biotechnologies Inc, a provider of living medicines for chronic diseases, has secured $33 million in Series A financing. DCVC Bio led the round with participation from 5AM Ventures, Alta Partners, Alexandria Venture Investments and Mayo Clinic.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: